Pten was selected because (a) single tumor suppressors usually do not yield overt ECs (35, 36, 38), (b) PTEN is the most frequently mutated gene in EC, and (c) PAX2 silencing and PTEN mutations frequently co-occur in EIN and EC (15). This evidence concerns the gene PTEN and neoplasm.